# Safety and Pharmacokinetic Study of Oral Morphine Sulfate in Pediatric Subjects

> **NCT01322360** · PHASE4 · COMPLETED · sponsor: **Roxane Laboratories** · enrollment: 50 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Morphine Sulfate

## Key facts

- **NCT ID:** NCT01322360
- **Lead sponsor:** Roxane Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01322360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01322360, "Safety and Pharmacokinetic Study of Oral Morphine Sulfate in Pediatric Subjects". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01322360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*